Steris Plc(STE) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | S&P 500 | P/E | 25.76 | EPS (ttm) | 8.18 | Insider Own | 0.34% | Shs Outstand | 97.5M | Perf Week | -7.08% |
| Market Cap | 20.55B | Forward P/E | 17.21 | EPS next Y | 9.3% | Insider Trans | -3.32% | Shs Float | 97.2M | Perf Month | -10.92% |
| Enterprise Value | 22.13B | PEG | 1.75 | EPS next Q | 2.68 | Inst Own | 100.04% | Short Float | 2.51% | Perf Quarter | 1.71% |
| Income | 0.81B | P/S | 3.4 | EPS this Y | 10.19% | Inst Trans | -0.08% | Short Ratio | 3.32 | Perf Half Y | -0.75% |
| Sales | 6.04B | P/B | 2.85 | EPS next 5Y | 9.81% | ROA | 7.62% | Short Interest | 2.44M | Perf YTD | -16.87% |
| Book/sh | 73.91 | P/C | 42.61 | EPS past 3/5Y | 95.07% 11.37% | ROE | 11.37% | 52W High | -21.78% ($269.44) | Perf Year | -16.51% |
| Cash/sh | 4.95 | P/FCF | 22.2 | Sales past 3/5Y | 9.38% 13.82% | ROIC | 8.97% | 52W Low | 8% ($195.14) | Perf 3Y | -7.88% |
| Dividend Est. | $2.68 (1.27%) | EV/EBITDA | 13.21 | EPS Y/Y TTM | 23.94% | Gross Margin | 45% | Volatility(W/M) | 2.3% 2% | Perf 5Y | 0.5% |
| Dividend TTM | 2.58 | EV/Sales | 3.66 | Sales Y/Y TTM | 8.37% | Oper. Margin | 19.61% | ATR (14) | 5.5 | Perf 10Y | 198.99% |
| Dividend Ex-Date | 2026/9/4 | Quick Ratio | 1.35 | EPS Q/Q | 13.83% | Profit Margin | 13.34% | RSI (14) | 26.74 | Recom | 1.92 |
| Dividend Gr. 3/5Y | 10.16% 9.4% | Current Ratio | 1.91 | Sales Q/Q | 7.3% | SMA20 | -8.06% ($229.24) | Beta | 0.93 | Target Price | $265.86 |
| Payout | 31.04% | Debt/Eq | 0.28 | Earnings | 2026/8/5 | SMA50 | -6.5% ($225.41) | Rel Volume | 0.79 | Prev Close | $212.45 |
| Employees | 17937 | LT Debt/Eq | 0.24 | EPS/Sales Surpr. | 3.82% 0.34% | SMA200 | -9.16% ($232.01) | Avg Volume(3M) | 0.74M | Price | $210.76 |
| IPO | 1992/6/1 | Option/Short | Yes/Yes | Trades | 9760 | Volume | 582,023 | Change | -0.8% |
Company
STE is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
🏥 STERIS (STE) is a global medical equipment company that comprehensively provides essential infection prevention solutions, sterilization equipment, and operating room devices to hospitals, surgery centers, pharmaceutical companies, and life science research laboratories worldwide.
Over the past 1 year, on the lower side
22% below its 1-year high.
STE makes money exceptionally well
19.61% of revenue is kept as operating profit.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +10.2% this year.
Tap to view numbers
The price looks about right
Trading at 25.8 times earnings.
Tap to view numbers
Results came in about as expected
Slight tendency to beat estimates
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Buy.
Tap to view numbers
Long-term returns are close to the market
Would have changed by -7.9% if bought 5 years ago.
Tap to view numbers
The dividend is on the small side
Pays 1.27% annually in dividends.
Tap to view numbers
Ownership looks stable
Institutions hold 100.0%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
Special products that amplify (leveraged) or invert this single stock. They decay quickly and are not for long-term holding.
It ranks #4 in the industry
Based on market cap of $21B.
FAQ
What kind of company is STE?
STE belongs to the Healthcare sector and operates in the Medical Devices industry.
What is the market cap of STE?
The market cap of STE is approximately $20.5B, ranking 604 within its sector.
Does STE pay dividends?
STE has a dividend yield of approximately 1.27%, with an annual dividend of $2.68.
What is the P/E ratio of STE?
STE has a P/E ratio of approximately 25.8x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for STE?
STE has recorded a 52-week high of $269.44 and a low of $195.14.